stoxline Quote Chart Rank Option Currency Glossary
  
(CRBD)
  0 (0%)    01-08 20:02
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2026-01-08 4:44:44 PM
Short term     
Mid term     
Targets 6-month :  27.78 1-year :  32.45
Resists First :  23.79 Second :  27.78
Pivot price 23.23
Supports First :  23.24 Second :  22.9
MAs MA(5) :  23.25 MA(20) :  23.22
MA(100) :  24.37 MA(250) :  24.22
MACD MACD :  -0.2 Signal :  -0.3
%K %D K(14,3) :  51.2 D(3) :  35.5
RSI RSI(14): 55.2
52-week High :  25.57 Low :  19.76
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CRBD ] has closed It is unclear right now based on current values. 47.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 23.63 - 23.72 23.72 - 23.83
Low: 22.9 - 23 23 - 23.11
Close: 23.43 - 23.58 23.58 - 23.77
Company Description

Headline News

Thu, 08 Jan 2026
How CRBD stock reacts to Fed rate cuts - Market Risk Report & Community Verified Trade Alerts - ulpravda.ru

Wed, 07 Jan 2026
Precision Trading with CRBD Company (CRBD) Risk Zones - Stock Traders Daily

Mon, 05 Jan 2026
Update Recap: Will CRBD stock benefit from infrastructure bill - July 2025 Decliners & Low Risk Growth Stock Ideas - moha.gov.vn

Mon, 05 Jan 2026
Market Review: How CRBD stock reacts to Fed rate cuts - Quarterly Trade Review & High Conviction Investment Ideas - moha.gov.vn

Sat, 27 Dec 2025
How CRBD Company (CRBD) Affects Rotational Strategy Timing - Stock Traders Daily

Sat, 20 Dec 2025
Tibial Nerve Stimulation Lowers Catheter-Related Bladder Discomfort After Surgery - European Medical Journal

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android